Skip to content
Screener

Aquestive Therapeutics, Inc. AQST Deferred Tax Assets and Other Non-Current Assets

Deferred Tax Assets and Other Non-Current Assets at other companies

Viatris logo
ViatrisVTRS
$1.06B-46.9%
AMP
Amphastar PharmaceuticalsAMPH
$33.39M+18.8%
Regenxbio logo
RegenxbioRGNX
$5.9M+214%
Absci Corporation logo
Absci CorporationABSI
$383K-46.5%
Indivior Pharmaceuticals, Inc. logo
Indivior Pharmaceuticals, Inc.INDV
AbbVie logo
AbbVieABBV

Other financials

Income statement

See full
Revenue$13.8M+38.1%
Gross profit$9.8M+80.1%
Operating income-$8.2M+27.7%
Net income-$22.9M-68.8%
EPS (diluted)-$0.18-28.6%

Balance sheet

See full
Cash & equivalents$98.5M+62.7%
Total debt$63.4M+6.0%
Total equity-$56.6M+22.0%
Total assets$132.1M+41.0%

Cash flow

See full
Operating cash flow-$9.4M-19.3%
CapEx$212.0K+98.1%
Free cash flow-$9.7M-20.3%

Valuation

See full
Market cap$494.34M+28.9%
Enterprise value$459.23M+20.0%
P/S9.1×+0.5×

Profitability

See full
Gross margin67%+5.9pp
Operating margin-97.5%-15.0pp
Net margin-144.6%-2.6pp
FCF margin-85%-17.0pp

Returns & leverage

See full
Return on equity121.1%
Debt / equity-1.1×
Current ratio7.2×+3.7×

Where this comes from

Reported directly by Aquestive Therapeutics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:OtherAssetsNoncurrent.

The source filing: Aquestive Therapeutics, Inc.’s 10-Q, filed August 11, 2026.

Filed
Aug 11, 2026, 4:10 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001398733-26-000042
Line itemJune 30,2026December 31,2025
Total current assets118,494149,269
Property and equipment, net3,9603,893
Right-of-use assets, net7,9494,621
Other non-current assets1,7012,642
Total assets$132,104$160,425
Liabilities and stockholders’ deficit
Current liabilities:
Accounts payable$8,965$29,862

Item 1. FINANCIAL STATEMENTS (Unaudited)

FAQ

What is Aquestive Therapeutics, Inc.'s deferred tax assets and other non-current assets?
Aquestive Therapeutics, Inc. (AQST) reported deferred tax assets and other non-current assets of $1.7M in Q2 2026.
How has Aquestive Therapeutics, Inc.'s deferred tax assets and other non-current assets changed year-over-year?
Aquestive Therapeutics, Inc.'s deferred tax assets and other non-current assets decreased by 47.0% year-over-year, from $3.21M to $1.7M.
What is the long-term trend for Aquestive Therapeutics, Inc.'s deferred tax assets and other non-current assets?
Over 5 years (2020 to 2025), Aquestive Therapeutics, Inc.'s deferred tax assets and other non-current assets has grown at a -9.6% compound annual growth rate (CAGR), from $7.84M to $4.72M.
What does deferred tax assets and other non-current assets mean?
Combined balance of non-current deferred tax assets and other miscellaneous non-current assets.

Ask your AI about Aquestive Therapeutics, Inc.'s deferred tax assets and other non-current assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude